Add Your Voice for Zepatier

Add Your Voice for ZepatierAdd your voice. Zepatier will soon be considered for BC PharmaCare coverage. Therefore, your input may soon be sought.

Tentatively, patient and caregiver input into Zepatier’s approval process will be requested from Wednesday March 23, 2016 to MIDNIGHT ON Wednesday April 20, 2016.

How to Add Your Voice to the BC PharmaCare Coverage Review for Zepatier

If you are a BC resident and answer yes to any of the following questions, you can give your input into whether or not the treatment should be covered by BC PharmaCare:

Please note that PharmaCare’s questionnaire for Zepatier input tentatively wont be available for another week. The Hepatitis C Treatment Information Project will follow this development and keep you updated.

Zepatier in Canada

Zepatier is an approved all-oral, short-course (8, 12, or 16 weeks), interferon-free treatment for genotypes 1, 3, or 4 hep C. It can be taken with or without ribavirin and with or without Sovaldi.

Links to Additional Zepatier Information

For more information, please contact BC PharmaCare’s Your Voice or the Hepatitis C Treatment Information Project.